Padmashree Gehl Sampath outlines the benefits of global collaboration in the manufacture of the COVID-19 vaccine, as well as the disconnect between availability and access for some of the most vulnerable communities.
“A year into the COVID-19 crisis, the virus has exposed and strengthened the global fault lines in healthcare. On the good side, the pandemic brought together governments, pharmaceutical companies, and academic/ research institutes in an unprecedented manner to actively forge new collaborations and produced impressive results..”